• 80% New Speakers
  •  2Tracks To Choose From
  •   Facility Site Tour in China

IBC’s 5th Annual Biomanufacturing Conference will examine the latest regulations impacting, analyse new and existing facilities, introduce cost saving technologies, and discuss best practices to meet the growth of biologic products in Asia. Key biological manufacturers will share their learnings, challenges and strategies to both advance and refine this developing industry. This conference also aims to provide a platform for key industry experts to have in-depth discussions on biomanufacturing facilities, process and quality.

2015 Key Conference Themes

  • Flexible Facilities & New Biomanufacturing Technologies
  • Commercialization & Scale-Up Strategies
  • Global Biotech Advances
  • New Projects
  • Biomanufacturing Project Design & Planning
  • Biomanufacturing Finance & Investment
  • Green & Energy Efficient Biomanufacturing Facilities
  • Production & Quality
  • Technology Transfer & cGMP
  • Biomanufacturing Supply Chain Efficiencies

To see full agenda, click here »

Featured Speakers

Richard O'Keeffe
Executive Director, International Quality – Japan-Asia-Pacific (JAPAC) Regional Quality Head, Amgen, Singapore

Lars Dreesmann
Executive Director Upstream Manufacturing & Tech Transfer H84 & PT&PE H84,  Boehringer Ingelheim Pharma, Germany

Shou-Bai Chao
Senior Vice President, Bio Ventures, Global Operations, AstraZeneca, China

Michelle Yu Xia
Chairman, President & CEO, Akeso Biopharma, China

Cuihua (Chloe) Liu
Executive Vice President, Quality & Regulatory Affair, Alphamab, China

To see full speakers line-up, click here »

Agenda at a Glance

Pre-Conference Workshop
Tuesday, 19 May 2015

Conference Day One
Wednesday, 20 May 2015

Conference Day Two
Thursday, 21 May 2015

Post-Conference Workshop
Friday, 22 May 2015

Workshop A
Boehringer Ingelheim Biopharmaceuticals Move to China - Operational Excellence and Experience in 30 years Commercial Manufacturing

 

Biopharma Visionary Keynote Sessions

Flexible Facilities & New Biomanufacturing Technologies

Global Biotech Advances

Workshop B
Best Corrective & Preventive Action (CAPA) & Root Cause Analysis Practices for Biomanufacturing Excellence

Networking Lunch & VIP Tables

Exclusive Site Tour to Boehringer Ingelheim’s New Biopharmaceuticals Facility in Shanghai, China

Commercialization & Scale-Up Strategies

Roundtable Discussions

Track A
Facilities

Track B
Process & Quality

(Continue)

Produced bySupporting AssociationGold sponsorAssociate sponsor

Exhibitors   
  
Media Partners   
IBC